111 (YI) Cash & Equivalents Growth (1y) (2018 - 2025)
111 (YI) Cash & Equivalents Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Akso Health |
2,315,158.81 Bn |
2,315,158.63 Bn |
- |
106.91% |
| 2 |
Mckesson |
92.76 Bn |
89.18 Bn |
4.04 Bn |
-30.15% |
| 3 |
Cencora |
52.82 Bn |
50.83 Bn |
3.59 Bn |
10.03% |
| 4 |
Cardinal Health |
52.17 Bn |
48.39 Bn |
2.50 Bn |
18.37% |
| 5 |
Henry Schein |
9.19 Bn |
9.71 Bn |
1.07 Bn |
8.66% |
| 6 |
Accendra Health |
246.88 Mn |
-90.00 Mn |
312.39 Mn |
466.79% |
| 7 |
Edap Tms |
161.92 Mn |
146.92 Mn |
8.15 Mn |
-39.13% |
| 8 |
111 |
107.47 Mn |
25.61 Mn |
23.58 Mn |
11.94% |
| 9 |
Cosmos Health |
9.42 Mn |
7.26 Mn |
1.38 Mn |
-30.72% |
| 10 |
Cellyan Biotechnology |
5.69 |
-2.48 Mn |
- |
-47.69% |
| Date | Value |
|---|
| Dec 31, 2025 |
11.94% |
| Sep 30, 2025 |
-14.09% |
| Jun 30, 2025 |
0.97% |
| Mar 31, 2025 |
-20.42% |
| Dec 31, 2024 |
-23.22% |
| Sep 30, 2024 |
-27.82% |
| Jun 30, 2024 |
-16.05% |
| Mar 31, 2024 |
-6.72% |
| Dec 31, 2023 |
-11.51% |
| Sep 30, 2023 |
3.65% |
| Jun 30, 2023 |
-16.85% |
| Mar 31, 2023 |
-23.76% |
| Dec 31, 2022 |
-8.44% |
| Sep 30, 2022 |
-6.41% |
| Jun 30, 2022 |
-37.84% |
| Mar 31, 2022 |
-19.52% |
| Dec 31, 2021 |
-42.37% |
| Sep 30, 2021 |
-33.96% |
| Jun 30, 2021 |
64.13% |
| Mar 31, 2021 |
98.23% |
